Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04697784 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Approval Study of the TREO Abdominal Stent-Graft System

Study acronym: TREO PAS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 300 to confirmed 338
    • Study sites revised (40)
    v5
  2. 2 versions Re-verified since May 13, 2022, no change to tracked fieldsv3-v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 31, 2021 to Jan 20, 2021
    • Site details revised at 40 of 40 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
Trial Details
NCT Number NCT04697784
Lead Sponsor Bolton Medical
Conditions
(from sponsor)		 Abdominal Aortic Aneurysm
Related terms Aortic Aneurysm, Abdominal
Enrollment 338 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov